Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
layoffs
Biotech
Valneva to lay off up to 15%, faces tough travel vaccine market
Valneva is planning to shrink its headcount by up to 15% as the French vaccine developer continues to seek ways to cut costs.
James Waldron
May 13, 2026 8:35am
After buyout, Gilead is laying off Arcellx staff on both coasts
May 5, 2026 3:12pm
Blocked by FDA, Passage cuts headcount by 75%
May 4, 2026 1:33pm
Fierce Biotech Layoff Tracker 2026: Autolus, Replimune & more
Apr 30, 2026 12:30pm
Shedding 60% of workforce, Replimune vows to continue operations
Apr 21, 2026 2:15am
Astellas closes stem cell unit’s Seattle site, layoffs incoming
Apr 14, 2026 10:45am
